Novartis AG Annual Shareholders Meeting Transcript
[Interpreted] So good morning, ladies and gentlemen, shareholders. I'd like to welcome you most warmly to our 27th Ordinary General Assembly of Novartis AG. And after that long break enforced by COVID, I'm delighted to see so many shareholders here in the St. Jakobshalle in Basel again.
I'd also like to welcome the members of the executive team who are here in the room as well as our new candidate for the Board of Directors, John Young; and the members of the Executive Committee who have joined us. Here in the room, we also have the representatives of KPMG, our auditors; our notary, Ms. Andrea Schmutz; and our independent proxy, Mr. Peter Andreas Zahn.
I hereby appoint Frau Charlotte Pamer, as the minute taker. She's the Secretary of the Board of Directors. And as tellers, I appoint the following gentlemen: Thomas Aegerter from UBS in Basel; Stephanino Isele from the Zürcher Kantonalbank and Marco Superina from Credit Suisse in Zurich.
This AGM was announced by publication in the Swiss commercial
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |